RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00035024.xml
PDF herunterladen
Thromb Haemost 2000; 83(05): 790-792
DOI: 10.1055/s-0037-1613914
DOI: 10.1055/s-0037-1613914
Letters to the Editor
Genotyping of the Stromelysin-1 5A/6A Promoter Polmorphism Using a Heteroduplex Generator
This work was supported by BHF Grants RG95007 and SG98003. The UHG used for this work is patented to Bristol University, British Patent No. 2280266
Weitere Informationen
Publikationsverlauf
Received
28. Oktober 1999
Accepted after revision
10. Januar 2000
Publikationsdatum:
08. Dezember 2017 (online)
-
References
- 1 Henney AM, Wakeley P, Davies MJ, Foster K, Hembry R, Murphy G, Humphries SE. Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. Proc Natl Acad Sci USA 1991; 88: 8154.
- 2 Murphy G, Reynolds JJ. Extracellular matrix degradation. In: Connective Tissue and Its Heritable Disorders. Wiley-Liss, Inc; 1993: 287.
- 3 Quinones S, Buttice G, Kurkinen M. Promoter elements in the transcriptional activation of the human stromelysin-1 gene by the inflammatory cytokine, interleukin 1. Biochem J 1994; 302: 471.
- 4 Ye S, Watts GF, Mandalia S, Humphries SE, Henney AM. Preliminary report: genetic variation in the human stromelysin promoter is associated with progression of coronary atherosclerosis. Br Heart J 1995; 73: 209.
- 5 Ye S, Eriksson P, Hamsten A, Kirkinen M, Humphries SE, Henney AM. Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression. J Biol Chem 1996; 271: 13055.
- 6 Humphries SE, Luong L-A, Talmud PJ, Frick MH, Kesaniemi YA, Pasternack A, Taskinen M-R, Syvanne M. The 5A/6A polymorphism in the promoter of the stromelysin-1 (MMP-3) gene predicts progression of angiographically determined coronary artery disease in men in the LOCAT gemfibrozil study. Atherosclerosis 1998; 139: 49-56.
- 7 de Maat MPM, Jukema W, Ye S, Zwinderman AH, Beekman M, Kastelein JJP, van Boven AJ, Ruschke AVG, Humphries SE, Kluft C, Henney AM. Efficacy of pravastatin treatment in coronary atherosclerosis is modulated by natural variation in the stromelysin-1 promoter. Am J Cardiol 1999; 83: 852-6.
- 8 Terashima M, Hozuka A, Kanazawa K, Inoue N, Yamada S, Ito K, Matsuda Y, Takai E, Iwai C, Kurogane H, Yoshida Y, Yokoyama M. Stromelysin promoter 5A/6A polymorphism is asociated with acute myocardial infarction. Circulation 1999; 99: 2717-9.
- 9 Wood N, Standen G, Hows J, Bradley B, Bidwell J. Diagnosis of sickle-cell disease with a universal heteroduplex generator. Lancet 1993; 342: 1519-20.
- 10 Wood N, Tyfield L, Bidwell J. Rapid classification of phenylketonuria genotypes by analysis of heteroduplexes generated by PCR-amplifiable synthetic DNA. Hum Mutat 1993; 02: 131-7.
- 11 Savage DA, Wood NA, Bidwell JL, Fitches A, Old JM, Hui KM. Detection of beta-thalassaemia mutations using DNA heteroduplex generator molecules. Br J Haematol 1995; 90: 564-71.
- 12 Wood N, Bidwell J. Genetic screening and testing by induced heteroduplex formation. Electrophoresis 1996; 17: 247-54.
- 13 Rose NC, Hurwitz C, Silberstein L, Andovalu R, Stoerker J. Prenatal analysis of rhesus CcDEe blood groups by heteroduplex generator. Am J Obstet Gynecol 1997; 176: 1084-9.
- 14 Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.